TWO · Healthcare

Genovate Biotechnology Co Ltd (4130)

Biotechnology

Genovate Biotechnology Co Ltd (4130) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 4130

P/E ratio

18.00

Genovate Biotechnology Co Ltd (4130) — FAQ

What is 4130's P/E ratio?

The price-to-earnings (P/E) ratio for Genovate Biotechnology Co Ltd (4130) is 18.00 (data as of 2026-03-23).

Does Genovate Biotechnology Co Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Genovate Biotechnology Co Ltd (4130). Check the MyAverix Finance app for the latest dividend data.

What sector is Genovate Biotechnology Co Ltd in?

Genovate Biotechnology Co Ltd (4130) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 4130 listed on?

4130 is listed on TWO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)